X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025)

X4 Pharmaceuticals (XFOR) posted Change in Inventory of $399000.0 for Q4 2025, down 56.15% on a QoQ basis from $910000.0 in Q3 2025, and up 7.26% year-over-year from $372000.0 in Q4 2024.

X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025) Analysis & Trends

X4 Pharmaceuticals' Change in Inventory history runs 2 years deep, the most recent figure standing at $399000.0 for Q4 2025.

  • Quarterly Change in Inventory rose 7.26% year-over-year to $399000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 41.0% YoY) and the FY2025 annual result came in at $1.7 million, down 41.0% from the prior year.
  • Change in Inventory was $399000.0 for Q4 2025 at X4 Pharmaceuticals, down from $910000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.6 million in Q3 2024 and bottomed at $81000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn 71.84 Mn
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 3.32 Mn
10 X4 Pharmaceuticals 167.86 Mn -49.18 Mn 2.20 Mn 399,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 399,000.00
Dec 31, 2025 399,000.00
Sep 30, 2025 910,000.00
Sep 30, 2025 910,000.00
Jun 30, 2025 81,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 272,000.00
Mar 31, 2025 272,000.00
Dec 31, 2024 372,000.00
Dec 31, 2024 372,000.00
Sep 30, 2024 1.61 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 831,000.00
Jun 30, 2024 831,000.00